NCT04763200

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2021-04-13Est. Completion: 2026-10

Enrollment target: 1,252 participants

Locations

University of Alabama, Birmingham, Alabama, United States
St. Joseph's Medical Center - Phoenix, Phoenix, Arizona, United States
Northwest Medical Center Tucson, Tucson, Arizona, United States
Arkansas Cardiology, Little Rock, Arkansas, United States
Adventist Health Glendale, Glendale, California, United States
St. Joseph Hospital - Orange, Orange, California, United States
Loma Linda University Health, San Bernardino, California, United States
UCSD Medical Center, San Diego, California, United States
Colorado Heart and Vascular, Lakewood, Colorado, United States
Hartford Hospital, Hartford, Connecticut, United States
MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States
The Cardiac & Vascular Institute, Gainesville, Florida, United States
University of Florida Health - Gainesville, Gainesville, Florida, United States
UF Health Jacksonville, Jacksonville, Florida, United States
Emory University Hospital, Atlanta, Georgia, United States
Northside Cardiovascular Institute, Lawrenceville, Georgia, United States

Atrial FibrillationHeart Failure

This cluster randomized study aims to compare village doctor-led integrated care versus usual care to improve cardiovasc…

Yancheng, ChinaEst. completion Jul 1, 2030

Prosthesis SurvivalProsthesis; Cardiac, Heart, Functional Disturbance as Result

The mechanical intervention is treating aortic valve stenosis (AVS) which may be performed using the standard open surgi…

Saint-Denis, FranceCompleted Dec 1, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.